Sign Out
Symptoms and Signs: ARIXTRA doses above the recommended regimen may lead to an increased risk of bleeding.
Treatment: Overdose associated with bleeding complications should lead to treatment discontinuation and search for the primary cause. Initiation of appropriate therapy which may include surgical haemostasis, blood replacements, fresh plasma transfusion, plasmapheresis should be considered.
